RxDoctor Payments Data

Alan Epstein

Clinical Pathology · Los Angeles, CANPI 1215174503

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $530,524 of the $530,774 with a category attached, or 100.0%. EMD Millipore Corporation accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. Among clinical pathology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$530,774in general payments, 2019–2025

Across 72 payments — averaging $7371.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Millipore Corporation$531K
  • AbbVie$125
  • Dendreon Pharmaceuticals LLC$125

What the payments were for

  • Royalty or licence$530,524100%
  • Food & beverage$2500%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Millipore Corporation70$530,524
AbbVie1$125
Dendreon Pharmaceuticals LLC1$125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$530,774 in reported general payments places this provider in the 95th percentile of 20 clinical pathology providers in California.

See all clinical pathology providers in California

Other clinical pathology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →